Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls

Abstract

Protein-coding genetic variants that strongly affect disease risk can yield relevant clues to disease pathogenesis. Here we report exome-sequencing analyses of 20,791 individuals with type 2 diabetes (T2D) and 24,440 non-diabetic control participants from 5 ancestries. We identify gene-level associations of rare variants (with minor allele frequencies of less than 0.5%) in 4 genes at exome-wide significance, including a series of more than 30 SLC30A8 alleles that conveys protection against T2D, and in 12 gene sets, including those corresponding to T2D drug targets (P = 6.1 × 10−3) and candidate genes from knockout mice (P = 5.2 × 10−3). Within our study, the strongest T2D gene-level signals for rare variants explain at most 25% of the heritability of the strongest common single-variant signals, and the gene-level effect sizes of the rare variants that we observed in established T2D drug targets will require 75,000–185,000 sequenced cases to achieve exome-wide significance. We propose a method to interpret these modest rare-variant associations and to incorporate these associations into future target or gene prioritization efforts. Exome-sequencing analyses of a large cohort of patients with type 2 diabetes and control individuals without diabetes from five ancestries are used to identify gene-level associations of rare variants that are associated with type 2 diabetes.

Cited by papers we hold 7

• Applications of multi‐omics analysis in human diseases · 2023
  No notice
• Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci · 2022
  No notice
• Trends in insulin resistance: insights into mechanisms and therapeutic strategy · 2022
  No notice
• Zinc transporters and their functional integration in mammalian cells · 2021
  No notice
• Regulation of inflammation in diabetes: From genetics to epigenomics evidence · 2020
  Not checked
• Genome-wide rare variant analysis for thousands of phenotypes in over 70,000 exomes from two cohorts · 2020
  No notice
• Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.